ERBB2 and breast cancer: Breast cancers are known frequently to over-express several TAs, such as carcinoembryonic antigen, MUC1, HER2/neu, P53 and members of the MAGE family, but little is known about detection of pre-existing T-cell responses, and the rationale for initiating vaccination strategies remains to be fully established.